Skip to content

Inspection Record

Strive Pharmacy LLC — FDA 483 Findings

US FDAInspected 2026-09-28Published 2026-11-13 3 findingsContamination controlAseptic processing and sterility assuranceTraining and personnel

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

Microbial contamination was present in the ISO 5 area and areas adjacent to production areas.

2Aseptic processing and sterility assurance

Smoke studies were inadequately performed under dynamic conditions.

3Training and personnel

Personnel donned gowning apparel improperly, in a way that may have caused the gowning apparel to become contaminated.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Strive Pharmacy LLC company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.